Aktie PRLD PROLIGHT DIAGNOSTICS AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Prolight Diagnostics AB

Aktien

PRLD

SE0003618230

PRLD

Schlusskurs NORDIC GROWTH MARKET
Andere Börsenplätze
 00:00:00 24.06.2024 		% 5 Tage % 1. Jan.
0,143 SEK +10,85 % Intraday Chart für Prolight Diagnostics AB -10,62 % -52,49 %
25.06. Prolight Diagnostics und TTP geben Update zur MicroFlex-Entwicklung CI
17.05. Prolight Diagnostics AB (publ) meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BioStock: Prolight's partner TTP provides update on MicroFlex development
Prolight Diagnostics and TTP Provides Update on MicroFlex Development
Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million
BioStock: Prolight Diagnostics strengthens board with experienced business developer
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024
BioStock: Prolight Diagnostics CSO comments on latest data
Prolight on track for clinical performance studies
BioStock: Prolight Diagnostics' CTO thrilled to receive UK government grant
Equity Research | Prolight Diagnostics: SEK 17m UK grant a welcome external validation
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today
Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development
Prolight Diagnostics publishes quarterly report Q1, 2024
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share
BioStock: Prolight Diagnostics selects partner to conduct clinical validation studies
Prolight selects MDx CRO for the clinical performance studies for Psyros™
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. PRLD Aktie
  4. Nachrichten Prolight Diagnostics AB
  5. Andere Sprachen